TRINTELLIX DIN 02432943
Status: Marketed
Holder: LUNDBECK CANADA INC
Molecule: VORTIOXETINE (VORTIOXETINE HYDROBROMIDE)
Available to quote
Health Canada record
| Active ingredient(s) | VORTIOXETINE (VORTIOXETINE HYDROBROMIDE) 20 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N06AX26 VORTIOXETINE |
| Original market date | 28-Oct-2014 |
| Current status date | 28-Oct-2014 |
| Source | Health Canada DPD |
Establishment licence of the holder
Lundbeck Canada Inc — licence 100814, currently licensed, last inspection rating C (2023-04-11).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing VORTIOXETINE (VORTIOXETINE HYDROBROMIDE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02552744 | APO-VORTIOXETINE | APOTEX INC | Tablet | VORTIOXETINE (VORTIOXETINE HYDROBROMIDE) 5 MG | Marketed |
| 02552752 | APO-VORTIOXETINE | APOTEX INC | Tablet | VORTIOXETINE (VORTIOXETINE HYDROBROMIDE) 10 MG | Marketed |
| 02552760 | APO-VORTIOXETINE | APOTEX INC | Tablet | VORTIOXETINE (VORTIOXETINE HYDROBROMIDE) 15 MG | Approved |
| 02552779 | APO-VORTIOXETINE | APOTEX INC | Tablet | VORTIOXETINE (VORTIOXETINE HYDROBROMIDE) 20 MG | Marketed |
| 02432927 | TRINTELLIX | LUNDBECK CANADA INC | Tablet | VORTIOXETINE (VORTIOXETINE HYDROBROMIDE) 10 MG | Marketed |
| 02432935 | TRINTELLIX | LUNDBECK CANADA INC | Tablet | VORTIOXETINE (VORTIOXETINE HYDROBROMIDE) 15 MG | Approved |
| 02432919 | TRINTELLIX | LUNDBECK CANADA INC | Tablet | VORTIOXETINE (VORTIOXETINE HYDROBROMIDE) 5 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 16203 | 2014-10-22 | New Drug Submission (NDS) |